T. Rowe Price Associates’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29B | Buy |
|
|||||
|
2025
Q1 | $1.01B | Buy |
|
|||||
|
2024
Q4 | $828M | Buy |
|
|||||
|
2024
Q3 | $598M | Buy |
|
|||||
|
2024
Q2 | $21.3M | Buy |
|
|||||
|
2024
Q1 | $20.3M | Sell |
|
|||||
|
2023
Q4 | $359M | Buy |
|
|||||
|
2023
Q3 | $269M | Buy |
|
|||||
|
2023
Q2 | $215M | Buy |
|
|||||
|
2023
Q1 | $21.3M | Sell |
|
|||||
|
2022
Q4 | $201M | Sell |
|
|||||
|
2022
Q3 | $208M | Buy |
|
|||||
|
2022
Q2 | $150M | Buy |
|
|||||
|
2022
Q1 | $23.7M | Sell |
|
|||||
|
2021
Q4 | $32M | Sell |
|
|||||
|
2021
Q3 | $27.6M | Sell |
|
|||||
|
2021
Q2 | $27.3M | Sell |
|
|||||
|
2021
Q1 | $27.6M | Sell |
|
|||||
|
2020
Q4 | $27.8M | Sell |
|
|||||
|
2020
Q3 | $27.7M | Sell |
|
|||||
|
2020
Q2 | $28.8M | Sell |
|
|||||
|
2020
Q1 | $21.8M | Buy |
|
|||||
|
2019
Q4 | $26.7M | Buy |
|
|||||
|
2019
Q3 | $26.6M | Sell |
|
|||||
|
2019
Q2 | $26.1M | Buy |
|
|||||
|
2019
Q1 | $23M | Buy |
|
|||||
|
2018
Q4 | $19.7M | Buy |
|
|||||
|
2018
Q3 | $24.8M | Buy |
|
|||||
|
2018
Q2 | $24.9M | Sell |
|
|||||
|
2018
Q1 | $22.8M | Sell |
|
|||||
|
2017
Q4 | $23.1M | Sell |
|
|||||
|
2017
Q3 | $23.3M | Sell |
|
|||||
|
2017
Q2 | $28.4M | Sell |
|
|||||
|
2017
Q1 | $28.1M | Sell |
|
|||||
|
2016
Q4 | $26.8M | Sell |
|
|||||
|
2016
Q3 | $24.9M | Sell |
|
|||||
|
2016
Q2 | $24.5M | Sell |
|
|||||
|
2016
Q1 | $237M | Buy |
|
|||||
|
2015
Q4 | $222M | Sell |
|
|||||
|
2015
Q3 | $193M | Buy |
|
|||||
|
2015
Q2 | $221M | Sell |
|
|||||
|
2015
Q1 | $434M | Sell |
|
|||||
|
2014
Q4 | $505M | Buy |
|
|||||
|
2014
Q3 | $433M | Buy |
|
|||||
|
2014
Q2 | $412M | Sell |
|
|||||
|
2014
Q1 | $459M | Sell |
|
|||||
|
2013
Q4 | $499M | Buy |
|
|||||
|
2013
Q3 | $550M | Buy |
|
|||||
|
2013
Q2 | $460M | Buy |
|